MRNA

Moderna Inc (MRNA)

Healthcare • NASDAQ$61.00+2.79%

Key Fundamentals
Symbol
MRNA
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Price
$61.00
Daily Change
+2.79%
Market Cap
$25.38B
Trailing P/E
N/A
Forward P/E
-15.21
52W High
$67.74
52W Low
$22.28
Analyst Target
$43.30
Dividend Yield
N/A
Beta
1.03
About Moderna Inc

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and c

Company website

Research MRNA on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Pricing · Terms · Privacy · ·

Loading...